YAMINI SAKUNALA: Open Payments
NPI 1457625022 · JACKSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,387 in 204 payments from 21 companies in 2025. Trend: 2023 $2,021 · 2024 $3,583 · 2025 $3,387
Food & beverage: $3,302Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $537 |
| Novartis Pharmaceuticals Corporation | 25 | $502 |
| Janssen Biotech, Inc. | 15 | $327 |
| Regeneron Healthcare Solutions, Inc. | 14 | $308 |
| Amgen Inc. | 11 | $262 |
| PFIZER INC. | 14 | $237 |
| Galderma Laboratories, L.P. | 19 | $209 |
| Organon LLC | 14 | $206 |
| Lilly USA, LLC | 12 | $166 |
| UCB, Inc. | 11 | $157 |
Products named: COSENTYX, DUPIXENT, SKYRIZI, TREMFYA, OTEZLA, CIBINQO, RINVOQ, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
